147 related articles for article (PubMed ID: 32964748)
1. The Prognostic Impact of Body Mass Index in Patients with Diffuse Large B-Cell Lymphoma: A Meta-Analysis.
Wang Z; Luo S; Zhao X
Nutr Cancer; 2021; 73(11-12):2336-2346. PubMed ID: 32964748
[TBL] [Abstract][Full Text] [Related]
2. Body mass index as a prognostic factor in Asian patients treated with chemoimmunotherapy for diffuse large B cell lymphoma, not otherwise specified.
Hwang HS; Yoon DH; Suh C; Huh J
Ann Hematol; 2015 Oct; 94(10):1655-65. PubMed ID: 26174908
[TBL] [Abstract][Full Text] [Related]
3. Effect of body mass index on survival of patients with stage I non-small cell lung cancer.
Xie HJ; Zhang X; Wei ZQ; Long H; Rong TH; Su XD
Chin J Cancer; 2017 Jan; 36(1):7. PubMed ID: 28069048
[TBL] [Abstract][Full Text] [Related]
4. Analysis of the prognostic value of BMI and the difference in its impact according to age and sex in DLBCL patients.
Kanemasa Y; Shimoyama T; Sasaki Y; Tamura M; Sawada T; Omuro Y; Hishima T; Maeda Y
Hematol Oncol; 2018 Feb; 36(1):76-83. PubMed ID: 28449294
[TBL] [Abstract][Full Text] [Related]
5. Increased body mass index is associated with improved survival in United States veterans with diffuse large B-cell lymphoma.
Carson KR; Bartlett NL; McDonald JR; Luo S; Zeringue A; Liu J; Fu Q; Chang SH; Colditz GA
J Clin Oncol; 2012 Sep; 30(26):3217-22. PubMed ID: 22649138
[TBL] [Abstract][Full Text] [Related]
6. Anthropometrics and prognosis in diffuse large B-cell lymphoma: a multicentre study of 653 patients.
Bendtsen MD; Munksgaard PS; Severinsen MT; Bekric E; Brieghel C; Nielsen KB; Brown PN; Dybkaer K; Johnsen HE; Bøgsted M; El-Galaly TC
Eur J Haematol; 2017 Apr; 98(4):355-362. PubMed ID: 27893172
[TBL] [Abstract][Full Text] [Related]
7. Pretreatment Body Mass Index (BMI) as an Independent Prognostic Factor in Nasopharyngeal Carcinoma Survival: A Systematic Review and Meta-Analysis.
Jin X; Hu R; Guo H; Ding C; Pi G; Tian M
Nutr Cancer; 2022; 74(10):3457-3467. PubMed ID: 35658769
[TBL] [Abstract][Full Text] [Related]
8. Obesity is associated with increased relative risk of diffuse large B-cell lymphoma: a meta-analysis of observational studies.
Castillo JJ; Ingham RR; Reagan JL; Furman M; Dalia S; Mitri J
Clin Lymphoma Myeloma Leuk; 2014 Apr; 14(2):122-30. PubMed ID: 24360912
[TBL] [Abstract][Full Text] [Related]
9. The prognostic impact of BMI in patients with HR+/HER2- advanced breast cancer: a study of the SONABRE registry.
Lammers SWM; Thurisch H; Vriens IJH; Meegdes M; Engelen SME; Erdkamp FLG; Dercksen MW; Vriens BEPJ; Aaldering KNA; Pepels MJAE; van de Winkel LMH; Peters NAJB; Tol J; Heijns JB; van de Wouw AJ; Teeuwen NJA; Geurts SME; Tjan-Heijnen VCG
Breast Cancer Res Treat; 2024 Jan; 203(2):339-349. PubMed ID: 37878148
[TBL] [Abstract][Full Text] [Related]
10. Overweight/obese status associates with favorable outcome in patients with metastatic nasopharyngeal carcinoma: a 10-year retrospective study.
Li W; Shen LJ; Chen T; Sun XQ; Zhang Y; Wu M; Shu WH; Chen C; Pan CC; Xia YF; Wu PH
Chin J Cancer; 2016 Aug; 35(1):75. PubMed ID: 27507261
[TBL] [Abstract][Full Text] [Related]
11. The obesity paradox in patients with colorectal cancer: a systematic review and meta-analysis.
Li Y; Li C; Wu G; Yang W; Wang X; Duan L; Niu L; Chen J; Zhang Y; Zhou W; Liu J; Hong L; Fan D
Nutr Rev; 2022 Jun; 80(7):1755-1768. PubMed ID: 35182150
[TBL] [Abstract][Full Text] [Related]
12. Prognostic nutritional index and the prognosis of diffuse large b-cell lymphoma: a meta-analysis.
Luan C; Wang F; Wei N; Chen B
Cancer Cell Int; 2020; 20():455. PubMed ID: 32973400
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of baseline metabolic tumor volume and total lesion glycolysis in patients with lymphoma: A meta-analysis.
Guo B; Tan X; Ke Q; Cen H
PLoS One; 2019; 14(1):e0210224. PubMed ID: 30625203
[TBL] [Abstract][Full Text] [Related]
14. Impact of BMI on the Survival of Renal Cell Carcinoma Patients Treated with Targeted Therapy: A Systematic Review and Meta-Analysis.
Ji J; Yao Y; Guan F; Luo L; Zhang G
Nutr Cancer; 2023; 75(9):1768-1782. PubMed ID: 37462083
[TBL] [Abstract][Full Text] [Related]
15. [Evaluation of different staging systems and prognostic analysis of 110 primary gastrointestinal diffuse large B cell lymphoma].
Mao L; Wang X; Wang CY; Xia B; Ning QY; Yang HL; Yu Y; Zhang YZ
Zhonghua Yi Xue Za Zhi; 2019 Jun; 99(24):1853-1858. PubMed ID: 31269579
[No Abstract] [Full Text] [Related]
16. Prognostic value of red blood cell distribution width and D-Dimer in diffuse large B-cell lymphoma: Systematic review and meta-analysis.
Rahchamani M; Sedghi M; Hakimi A; Nejatianfar M; Javaheri T; Tavakoli R; Ahmadi R; Makarem M; Azmi-Naei N; Zahmatkesh Sangani S; Kamandi N; Soleimanian A; Shavaleh R; Foogerdi M; Rahmani K
Cancer Rep (Hoboken); 2024 Jan; 7(1):e1936. PubMed ID: 37997648
[TBL] [Abstract][Full Text] [Related]
17. Increased body mass index is associated with improved overall survival in diffuse large B-cell lymphoma.
Weiss L; Melchardt T; Habringer S; Boekstegers A; Hufnagl C; Neureiter D; Hopfinger G; Greil R; Egle A
Ann Oncol; 2014 Jan; 25(1):171-6. PubMed ID: 24299961
[TBL] [Abstract][Full Text] [Related]
18. Prognostic and clinicopathological impacts of systemic immune-inflammation index on patients with diffuse large B-cell lymphoma: a meta-analysis.
Fan Z; Shou L
Ther Adv Hematol; 2023; 14():20406207231208973. PubMed ID: 37954483
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of geriatric nutritional risk index in patients with diffuse large B-cell lymphoma: a meta-analysis.
Yan C; Xie Y; Hua Y; Li S; Fu H; Cheng Z; Wu J
Clin Transl Oncol; 2024 Feb; 26(2):515-523. PubMed ID: 37438653
[TBL] [Abstract][Full Text] [Related]
20. Influence of Statins on the Survival Outcomes of Patients with Diffuse Large B Cell Lymphoma: A Systematic Review and Meta-Analysis.
Li Y; Zhou H; Zou L
Int J Clin Pract; 2022; 2022():5618290. PubMed ID: 35989867
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
